肾移植受者胃肠道症状管理偏好的离散选择实验
患者最偏好能完全缓解胃肠道症状、片剂剂型、维持现有饮食、减少药物负担和低费用的干预方案。
要点
- 患者对完全缓解胃肠道症状的偏好显著优于无改善(OR 15.3)。
- 片剂较粉剂更受偏好(OR 1.6),维持现有饮食较排除食物类别更受偏好(OR 6.0)。
- 患者愿每月支付AUD$142.20以实现胃肠道症状完全缓解。
核心结论
- 能高效缓解全部胃肠道症状、无需实质性饮食改变且为片剂剂型的干预措施最受肾移植受者偏好。
研究设计与样本
- 在澳大利亚3个肾内科单位对肾移植受者开展离散选择实验,采用多项logit模型量化偏好与权衡。
主要发现
- 患者偏好完全缓解胃肠道症状优于无改善(OR 15.3,95%CI 1.80–129.50)。
- 患者偏好片剂优于粉剂(OR 1.6,95%CI 1.27–2.08)。
- 患者偏好维持现有饮食优于排除食物类别(OR 6.0,95%CI 2.19–16.27)。
- 患者偏好减少药物负担(OR 1.4,95%CI 1.06–1.79)和更低费用(OR 0.98,95%CI 0.96–1.00)。
- 患者愿每月支付AUD$142.20(95%CI $83.90–$200.40)实现胃肠道症状完全缓解,或支付AUD$100.90(95%CI $9.60–$192.10)实现症状中度改善。
临床怎么用
- 未来针对肾移植受者胃肠道症状的干预设计可参考患者对完全缓解症状、片剂剂型、维持饮食和减少药物负担的偏好。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Gastrointestinal (GI) symptoms in kidney transplant are common and debilitating. We aimed to ascertain patients' preferences for GI symptom management options to help future interventions align with treatment priorities. METHODS: A discrete choice experiment was conducted with kidney transplant recipients in 3 Australian nephrology units. A multinomial logit model was used to quantify the preferences and trade-offs between 5 characteristics: cost, formulation, symptom burden, dietary changes, and medication quantities. RESULTS: Seventy patients participated (mean age ± SD: 47 ± 15 years, 56% female), 57% had GI symptoms. Patients preferred interventions that will achieve complete resolution of GI symptoms compared to no improvement (odds ratio [95% confidence interval]: 15.3 [1.80, 129.50]), were delivered as a tablet rather than a sachet (1.6 [1.27, 2.08]), retained their current diet compared to eliminating food groups (6.0 [2.19, 16.27]), reduced medication burden (1.4 [1.06, 1.79]), and had lower costs (0.98 [0.96, 1.00]). Participants would be willing to pay AUD$142.20 [$83.90, $200.40] monthly to achieve complete resolution of GI symptoms or AUD$100.90 [$9.60, $192.10] to have moderate improvement in symptoms. CONCLUSIONS: Interventions that are highly effective in relieving all GI symptoms without the need for substantive dietary changes, and in tablet form, are most preferred by kidney transplant recipients.
引用
- Cooper TE, Dalton A, Kieu A, et al. Patient Preferences for the Management of Gastrointestinal Symptoms in Kidney Transplantation: a Discrete Choice Experiment. Kidney Int Rep. 2023. PMID: 37850002. doi:10.1016/j.ekir.2023.07.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。